Sirturo

Chemical Namebedaquiline
Dosage FormTablet (oral; 20 mg, 100 mg)
Drug ClassAntibacterials
SystemRespiratory
CompanyJanssen Products
Approval Year2012

Indication

  • Indicated as part of combination therapy in adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multi-drug resistant tuberculosis (MDR-TB)
Last updated on 4/22/2022

More on this drug: Clinical Trials

Document TitleYearSource
Sirturo (bedaquiline) Prescribing Information.2012Janssen Therapeutics, Titusville, NJ

Have we missed a study, or would you like to comment on a study?